Ironwood Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
RJA
MCM
SPIA
Ironwood Financial's IHE Position: Q4 2021 in Review
Ironwood Financial sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2021, closing a stake of 297 shares — an estimated $18K sold.
Ironwood Financial first reported a position in IHE in Q3 2020 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 112 funds tracked by Wall St. Rank hold IHE as of Q4 2021.
- Ironwood Financial reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
- Ironwood Financial sold 297 iShares US Pharmaceuticals ETF shares in Q4 2021, an estimated $18K.
- Ironwood Financial first reported a position in iShares US Pharmaceuticals ETF in Q3 2020 and held it in 5 quarters.
- Ironwood Financial's iShares US Pharmaceuticals ETF position peaked at $18K in Q3 2021.
- 112 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2021.
Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.